• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number SN60WF
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Unspecified Infection (1930); Inflammation (1932)
Event Date 05/19/2018
Event Type  Injury  
Manufacturer Narrative
Evaluation summary: the product was not returned for analysis.The product history and batch records were reviewed and documentation indicated the product met release criteria.The product investigation could not identify a root cause.There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Event Description
A physician reported a case of toxic anterior segment syndrome/inflammation/endophthalmitis following an intraocular lens (iol) implant procedure.Additional information has been provided indicating that only one case was culture proven endophthalmitis.This specific case had a positive culture result.
 
Manufacturer Narrative
The manufacturer internal reference number is: (b)(4).
 
Event Description
Additional information was provided indicating that there was 1+ conjunctival inflammation, 3+ aqueous cell, aqueous fibrin and hypopyon.The patient experienced blackness of vision, dark lines, spots, photophobia, sharp shooting pain and foggy vision.The signs and symptoms were reported approximately 10 days postoperative.In the surgeon¿s opinion, this is late onset endophthalmitis and low virulence staph.Cultures were performed and the results were positive for staph and negative for coag.Moderate growth of staph coag negative (a).Three days later, the patient was given iv antibiotics.Approximately 3 weeks later a vitrectomy was performed.The intervention for the event was effective.The outcome of the event resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ NATURAL SINGLEPIECE IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
MDR Report Key8493386
MDR Text Key141261149
Report Number9612169-2019-00040
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 04/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Model NumberSN60WF
Device Catalogue NumberSN60WF.270
Device Lot Number21209732
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/13/2019
Initial Date FDA Received04/08/2019
Supplement Dates Manufacturer Received04/01/2019
Supplement Dates FDA Received04/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BALANCE SALT SOLUTION; BESIVANCE; CUSTOM PACK; FLUID MANAGEMENT SYSTEM; LIDOCAINE; PHACO TIP; POVIDONE IODINE 10%; POVIDONE IODINE 5%; PROVISC; UNSPECIFIED HANDPIECE; VISCOAT
Patient Outcome(s) Other; Required Intervention;
Patient Age70 YR
-
-